岡林 剛史

Medicine & Life Sciences

1. Colorectal Neoplasms 100%
2. Laparoscopy 48%
3. Rectal Neoplasms 46%
4. Colorectal Surgery 35%
5. Colonic Neoplasms 32%
6. Surgical Wound Infection 31%
7. Neoplasm Metastasis 30%
8. Recurrence 28%
9. Fluorouracil 23%
10. Ulcerative Colitis 23%
11. Meta-Analysis 23%
12. Colectomy 22%
13. Japan 22%
14. HSP27 Heat-Shock Proteins 20%
15. Anastomotic Leak 19%
16. Neoplasms 18%
17. Postoperative Complications 18%
18. Leucovorin 17%
19. Tegafur 16%
20. olanexidine 16%
21. Network Meta-Analysis 15%
22. Hernia 15%
23. Systematic Reviews 14%
24. Survival 13%
25. Crohn Disease 13%
26. Irinotecan 13%
27. Cetuximab 13%
28. Drug Therapy 13%
29. Confidence Intervals 12%
30. Adjuvant Chemotherapy 11%
31. Incidence 11%
32. Intraabdominal Infections 11%
33. Esophageal Neoplasms 11%
34. Therapeutics 10%
35. ErbB Receptors 10%
36. Multivariate Analysis 10%
37. Pouchitis 10%
38. Survival Rate 10%
39. Uracil 10%
40. Liver 10%
41. Povidone-Iodine 9%
42. Lymph Nodes 9%
43. Odds Ratio 9%
44. Disease-Free Survival 8%
45. Inguinal Hernia 8%
46. Obesity 8%
47. Randomized Controlled Trials 8%
48. Neoadjuvant Therapy 8%
49. Herniorrhaphy 8%
50. Elderly 7%